Nailfold Videocapillaroscopy in Patients with Central Serous Chorioretinopathy and Its Relationship to Morphological and Functional Findings
Abstract
:1. Introduction
2. Experimental Section
2.1. Materials and Methods
2.1.1. The Study Groups
2.1.2. Ophthalmologic Examination
2.1.3. Nailfold Videocapillaroscopy in the CSC Patients and HCs
2.1.4. Statistical Analysis
3. Results
3.1. Comparison of NVC Pattern between CSC and HCs
3.2. Relationship between NVC Results and Ophthalmic Features in CSC Group
3.3. Correlations between NVC Pattern and General Risk Factors and OCT Features
4. Discussion
5. Conclusions
Author Contributions
Funding
Conflicts of Interest
References
- Erdem Toslak, I.; Erol, M.K.; Toslak, D.; Cekic, B.; Barc Ergun, M.; Lim-Dunham, J.E. Is the unaffected eye really unaffected? Color Doppler ultrasound findings in unilaterally active central serous chorioretinopathy. J. Med. Ultrason. (2001) 2017, 44, 173–181. [Google Scholar] [CrossRef]
- Kilic, D.; Karahan, M.; Vural, E.; Dursun, M.E.; Demirtaş, A.A. Abnormal retrobulbar blood flow variables in central serous chorioretinopathy. J. Clin. Ultrasound 2020, 48, 405–409. [Google Scholar] [CrossRef] [PubMed]
- Cutolo, M.; Pizzorni, C.; Sulli, A. Capillaroscopy. Best Pract. Res. Clin. Rheumatol. 2005, 19, 437–452. [Google Scholar] [CrossRef] [PubMed]
- Ingegnoli, F.; Gualtierotti, R.; Lubatti, C.; Bertolazzi, C.; Gutierrez, M.; Boracchi, P.; Fornili, M.; De Angelis, R. Nailfold capillary patterns in healthy subjects: A real issue in capillaroscopy. Microvasc. Res. 2013, 90, 90–95. [Google Scholar] [CrossRef] [PubMed]
- Kosior-Jarecka, E.; Bartosińska, J.; Łukasik, U.; Wróbel-Dudzińska, D.; Krasowska, D.; Chodorowska, G.; Żarnowski, T. Results of Nailfold Capillaroscopy in Patients with Normal-Tension Glaucoma. Curr. Eye Res. 2018, 43, 747–753. [Google Scholar] [CrossRef] [PubMed]
- Maric, V.; Grgurevic, A.; Cirkovic, A.; Stankovic, S.; Marjanovic, I.; Milovanovic, J.; Milovanovic, A.; Bozic, M. Nailfold capillary morphology and platelet function in patients with exfoliative glaucoma. PLoS ONE 2019, 14, e0219505. [Google Scholar] [CrossRef]
- Erol, M.K.; Balkarli, A.; Toslak, D.; Dogan, B.; Durmaz, D.; Süren, E.; Altun, S.; Bulut, M.; Cobankara, V. Evaluation of nailfold videocapillaroscopy in central serous chorioretinopathy. Graefes Arch. Clin. Exp. Ophthalmol. 2016, 254, 1889–1896. [Google Scholar] [CrossRef]
- Van Rijssen, T.J.; van Dijk, E.H.C.; Yzer, S.; Ohno-Matsui, K.; Keunen, J.E.E.; Schlingemanne, R.O.; Sivaprasad, S.; Querques, G.; Downes, S.M.; Fauser, S.; et al. Central serous chorioretinopathy: Towards an evidence-based treatment guideline. Prog. Retin. Eye Res. 2019, 73, 100770. [Google Scholar] [CrossRef] [PubMed]
- Smith, V.; Herrick, A.L.; Ingegnoli, F.; Damjanov, N.; De Angelis, R.; Denton, C.P.; Distler, O.; Espejo, K.; Foeldvari, I.; Frech, T.; et al. Standardisation of nailfold capillaroscopy for the assessment of patients with Raynaud’s phenomenon and systemic sclerosis. Autoimmun. Rev. 2020, 19, 102458. [Google Scholar] [CrossRef] [PubMed]
- Gallucci, F.; Russo, R.; Buono, R.; Acampora, R.; Madrid, E.; Uomo, G. Indications and results of videocapillaroscopy in clinical practice. Adv. Med. Sci. 2008, 53, 149–157. [Google Scholar] [CrossRef] [Green Version]
- Yava, G.F.; Küsbeci, T.; Ka ikci, M.; Günay, E.; Doğan, M.; Unlü, M.; Inan, U.Ü. Obstructive sleep apnea in patients with central serous chorioretinopathy. Curr. Eye Res. 2014, 39, 88–92. [Google Scholar] [CrossRef]
- Borrelli, E.; Zuccaro, B.; Zucchiatti, I.; Parravano, M.; Querques, L.; Costanzo, E.; Sacconi, R.; Prascina, F.; Scarinci, F.; Bandello, F.; et al. Optical Coherence Tomography Parameters as Predictors of Treatment Response to Eplerenone in Central Serous Chorioretinopathy. J. Clin. Med. 2019, 8, 1271. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Lee, H.; Lee, J.; Chung, H.; Kim, H.C. Baseline spectral domain optical coherence tomographic hyperreflective foci as a predictor of visual outcome and recurrence for central serous chorioretinopathy. Retina 2016, 36, 1372–1380. [Google Scholar] [CrossRef]
- Yuksel, E.P.; Yuksel, S.; Soylu, K.; Aydin, F. Microvascular abnormalities in asymptomatic chronic smokers: A videocapillaroscopic study. Microvasc. Res. 2019, 124, 51–53. [Google Scholar] [CrossRef]
- Hsu, H.-J.; Lee, C.h.-L.; Chao, S.C.; Nien, C.W.; Tzeng, S.H.; Huang, J.Y.; Ko, T.C.; Yang, S.F.; Lin, H.Y. The Correlation of Central Serous Chorioretinopathy and Subsequent Cardiovascular Diseases of Different Types: A Population-Based Cohort Study. Int. J. Environ. Res. Public Health 2019, 16, 5099. [Google Scholar] [CrossRef] [Green Version]
- Chatziralli, I.; Kabanarou, S.A.; Parikakis, E.; Chatzirallis, A.; Xirou, T.; Mitropoulos, P. Risk factors for central serous chorioretinopathy: Multivariate approach in a case-control study. Curr. Eye Res. 2017, 42, 1069–1073. [Google Scholar] [CrossRef] [PubMed]
- Chen, S.N.; Chen, Y.C.; Lian, I. Increased risk of coronary heart disease in male patients with central serous chorioretinopathy: Results of a population-based cohort study. Br. J. Ophthalmol. 2014, 98, 110–114. [Google Scholar] [CrossRef] [Green Version]
- Tsai, D.C.; Huang, C.C.; Chen, S.J.; Chou, P.; Chung, C.M.; Chan, W.L.; Huang, P.H.; Chen, T.J.; Lin, S.J.; Chen, J.W.; et al. Central serous chorioretinopathy and risk of ischaemic stroke: A population-based cohort study. Br. J. Ophthalmol. 2012, 96, 1484–1488. [Google Scholar] [CrossRef] [PubMed]
- McAloon, C.J.; Osman, F.; Glennon, P.; Lim, P.B.; Hayat, S.A. Chapter 4—Global epidemiology and incidence of cardiovascular disease. In Cardiovascular Diseases; Papageorgiou, N., Ed.; Academic Press: Boston, MA, USA, 2016; pp. 57–96. [Google Scholar]
- Daruich, A.; Matet, A.; Behar-Cohen, F. Central serous chorioretinopathy. Dev. Ophthalmol. 2017, 58, 27–38. [Google Scholar] [PubMed]
Variables | CSC (N = 59); n (%) | HCs (N = 53); n (%) |
Gender (Female/Male) | Female, 14 (23.72%) | Female, 13 (24.52%) |
Male, 45 (76.27%) | Male, 40 (75.47%) | |
Mean Age (Years) | 47.2 ± 9.4 | 46 ± 11.5 |
Place of habitation (Town/Village) | Town, 33 (55.93%) | Town, 30 (56.6%) |
Village, 26 (44.06%) | Village, 23 (43.39%) | |
Occupational Stress | 13 (22.03%) | 12 (22.64%) |
Smoking | 9 (15.25%) | 8 (15.09%) |
Steroids | 7 (11.86%) | 0 |
Hands freezing | 7 (11.83%) | 0 |
Xylomoetazolin | 4 (6.78%) | 0 |
Phosphodiesterase inhibitor | 1 (1.69%) | 0 |
Helicobacter pylori infection | 2 (3.39%) | 0 |
Hypertension | 3 (5.08%) | 0 |
Bronchial asthma | 2 (3.39%) | 0 |
Peptic ulcer disease | 1 (1.69%) | 0 |
Vitiligo | 1 (1.69%) | 0 |
Arthrosis | 1 (1.69%) | 0 |
Psoriasis | 1 (1.69%) | 0 |
Epilepsy | 1 (1.69%) | 0 |
Variables | CSC (N = 59), n (%) | HCs (N = 53), n (%) | p < 0.05 |
NVC pattern (abnormal) | 20 (33.89%) | 4 (7.54%) | 0.007 * |
Disorganization of the capillary architecture | 12 (20.34%) | 4 (7.54%) | 0.195 |
Hands freezing | 7 (11.86%) | 0 | |
Dilated apical part of capillaries | 17 (28.81%) | 0 | |
Dilated capillaries (diameter > 14 µm) | 28 (47.56%) | 7 (13.21%) | 0.004 * |
Enlarged capillaries (diameter 30–50 µm) | 22 (37.29%) | 0 | 0.007 * |
Ramified capillaries and neoangiogenesis | 23 (38.98%) | 3 (5.66%) | 0.000 * |
Tortuous capillaries | 38 (64.40%) | 23 (43.39%) | 0.651 |
Glomerular capillaries | 19 (32.20%) | 1 (1.88%) | 0.000 * |
Aneurysmal dilatations | 6 (10.17%) | 0 | |
Broken capillaries | 3 (5.08%) | 0 | |
Fresh capillary microhemorrhages | 2 (3.39%) | 0 | |
Megacapillaries (diameter > 50 µm) | 1 (1.69%) | 0 | |
Meandering capillaries | 17 (28.81%) | 15 (28.30%) | 0.306 |
Bizarre capillaries | 3 (5.08%) | 0 |
Variables | RPE Alteration | PED | Hyperreflective Foci | EZ Layer Disruption | SRF Hight | CRT |
---|---|---|---|---|---|---|
NVC pattern (abnormal) | −0.0 | 0.1 | 0.1 | 0.2 | 0.2 | 0.2 |
Hands freezing | −0.1 | 0.1 | 0.2 | 0.4 * | 0.0 | −0.1 |
Disorganization of the capillary architecture | −0.0 | 0.1 | 0.2 | 0.1 | 0.0 | 0.1 |
Dilated apical part of capillaries | −0.0 | 0.0 | 0.1 | 0.3 * | 0.1 | 0.0 |
Enlarged capillaries (diameter 30–50 µm) | −0.1 | 0.1 | 0.3 * | 0.3 | -0.2 | −0.1 |
Diameter | −0.1 | 0.1 | −0.0 | 0.0 | -0.1 | −0.0 |
Ramified capillaries and neoangiogenesis | 0.1 | 0.1 | 0.3 * | 0.0 | 0.1 | 0.1 |
Tortuous capillaries | 0.0 | 0.0 | −0.0 | 0.0 | 0.0 | 0.0 |
Glomerular capillaries | −0.8 | −0.2 | −0.3 * | −0.1 | −0.1 | −0.0 |
Aneurysmal dilatations | 0.1 | −0.1 | 0.0 | −0.2 | −0.1 | −0.0 |
Broken capillaries | −0.1 | −0.1 | 0.1 | 0.1 | 0.1 | 0.0 |
Fresh capillary microhemorrhages | 0.1 | −0.1 | 0.1 | 0.1 | −0.1 | −0.2 |
Megacapillaries (diameter > 50 µm) | 0.1 | −0.1 | 0.1 | −0.1 | -0.0 | −0.0 |
Meandering capillaries | 0.1 | −0.1 | 0.3 * | 0.0 | 0.2 | 0.1 |
Bizarre capillaries | 0.1 | −0.1 | 0.1 | −0.1 | 0.0 | −0.0 |
Variables | BCDVA | BCNVA | AT | MI |
---|---|---|---|---|
NVC pattern | −0.2 | 0.4 * | −0.3 | 0.1 |
Hands freezing | −0.2 | 0.1 | −0.3 | 0.2 |
Disorganization of the capillary architecture | 0.1 | 0.2 | −0.1 | −0.0 |
Dilated apical part of capillaries | −0.4 * | 0.3 * | −0.2 | 0.2 |
Enlarged capillaries (diameter 30–50 µm) | −0.2 | 0.2 | −0.2 | 0.1 |
Diameter | −0.1 | 0.1 | −0.2 | 0.1 |
Ramifiedcapillaries and neoangiogenesis | −0.4 * | 0.1 | −0.2 | 0.1 |
Tortuous capillaries | 0.2 | −0.0 | 0.5 * | −0.4 * |
Glomerular capillaries | 0.3 * | −0.0 | 0.3 * | −0.2 |
Aneurysmal dilatations | 0.2 | −0.2 | 0.2 | −0.2 |
Broken capillaries | −0.1 | 0.2 | −0.1 | 0.2 |
Fresh capillary microhemorrhages | −0.1 | 0.0 | NA | NA |
Megacapillaries (diameter > 50 µm) | 0.1 | −0.1 | NA | NA |
Meandering loops | 0.0 | 0.2 | 0.0 | −0.1 |
Bizarre loops | 0.1 | 0.0 | −0.1 | 0.0 |
Variables | Stress | Steroid | Smoking |
---|---|---|---|
Pattern of NVC | 0.2 | −0.1 | −0.0 |
Hands freezing | −0.1 | −0.1 | −0.0 |
Disorganization of the capillary architecture | −0.2 | 0.2 | 0.0 |
Dilated apical parts of capillaries | 0.3 * | 0.2 | −0.1 |
Enlarged capillaries (diameter 30–50 µm) | −0.1 | −0.0 | 0.0 |
Diameter | −0.0 | 0.0 | −0.1 |
Tortuous capillaries | 0.0 | −0.1 | 0.3 * |
Glomerular capillaries | 0.2 | 0.2 | 0.1 |
Aneurysmal dilatations | 0.2 | 0.1 | 0.0 |
Broken capillaries | 0.0 | 0.1 | 0.1 |
Fresh capillary microhemorrhages | 0.1 | −0.1 | 0.2 |
Megacapillaries (diameter > 50 µm) | −0.1 | 0.0 | 0.3 * |
Meandering loops | −0.1 | −0.1 | −0.1 |
Bizarre loops | 0.1 | 0.1 | 0.1 |
BCDVA | −0.3 * | −0.0 | 0.2 |
BCNVA | −0.0 | 0.0 | 0.0 |
AT | −0.3 * | −0.1 | −0.1 |
MI | 0.1 | 0.1 | 0.3 * |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Latalska, M.; Bartosińska, J.; Kosior-Jarecka, E.; Krasowska, D.; Mackiewicz, J. Nailfold Videocapillaroscopy in Patients with Central Serous Chorioretinopathy and Its Relationship to Morphological and Functional Findings. J. Clin. Med. 2020, 9, 3891. https://doi.org/10.3390/jcm9123891
Latalska M, Bartosińska J, Kosior-Jarecka E, Krasowska D, Mackiewicz J. Nailfold Videocapillaroscopy in Patients with Central Serous Chorioretinopathy and Its Relationship to Morphological and Functional Findings. Journal of Clinical Medicine. 2020; 9(12):3891. https://doi.org/10.3390/jcm9123891
Chicago/Turabian StyleLatalska, Małgorzata, Joanna Bartosińska, Ewa Kosior-Jarecka, Dorota Krasowska, and Jerzy Mackiewicz. 2020. "Nailfold Videocapillaroscopy in Patients with Central Serous Chorioretinopathy and Its Relationship to Morphological and Functional Findings" Journal of Clinical Medicine 9, no. 12: 3891. https://doi.org/10.3390/jcm9123891
APA StyleLatalska, M., Bartosińska, J., Kosior-Jarecka, E., Krasowska, D., & Mackiewicz, J. (2020). Nailfold Videocapillaroscopy in Patients with Central Serous Chorioretinopathy and Its Relationship to Morphological and Functional Findings. Journal of Clinical Medicine, 9(12), 3891. https://doi.org/10.3390/jcm9123891